Recital 2, Regulation (EU) 2019/2094

In forcesince 29 Nov 2019

The approval period of the active substances dimoxystrobin, mancozeb, mecoprop-P, metiram, oxamyl and pyraclostrobin was extended until 31 January 2020 by Commission Implementing Regulation (EU) 2018/1796 [Commission Implementing Regulation (EU) 2018/1796 of 20 November 2018 amending Implementing Regulation (EU) No 540/2011 as regards the extension of the approval periods of the active substances amidosulfuron, bifenox, chlorpyrifos, chlorpyrifos-methyl, clofentezine, dicamba, difenoconazole, diflubenzuron, diflufenican, dimoxystrobin, fenoxaprop-p, fenpropidin, lenacil, mancozeb, mecoprop-p, metiram, nicosulfuron, oxamyl, picloram, pyraclostrobin, pyriproxyfen and tritosulfuron (OJ L 294, 21.11.2018, p. 15).].